Characteristics of hospital-acquired and community-onset blood stream infections, South-East Austria

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Hoenigl, Martin ^a,b   Wagner, Jasmin ^a   Raggam, Reinhard B ^a   Prueller, Florian ^a   Prattes, Juergen ^a   Eigl, Susanne ^a   Leitner, Eva ^a   Hönigl, Katharina ^a   Valentin, Thomas ^a   Zollner Schwetz, Ines ^a   Grisold, Andrea J ^a   Krause, Robert ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; INTERLEUKIN 6; PROCALCITONIN;

ACINETOBACTER; ACTINOMYCES NAESLUNDII; ADULT; AGE; AGED; AGROBACTERIUM TUMEFACIENS; ARTICLE; AUSTRIA; BACTEROIDES; BIFIDOBACTERIUM; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA; CITROBACTER; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; CORYNEBACTERIUM; CREATININE BLOOD LEVEL; DELFTIA ACIDOVORANS; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; HUMAN; KLEBSIELLA; LEUKOCYTE COUNT; LISTERIA; MAJOR CLINICAL STUDY; MALE; MICROCOCCUS; MORGANELLA MORGANII; MORTALITY; NEISSERIA MENINGITIDIS; NEUTROPHIL COUNT; PREDICTION; PROPIONIBACTERIUM ACNES; PROSPECTIVE STUDY; PROTEUS; PSEUDOMONAS; ROTHIA DENTOCARIOSA; SALMONELLA; SERRATIA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS; STREPTOCOCCUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ESCHERICHIA COLI INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AUSTRIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84905643365     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104702     Document Type: Article

References (33)

1. Laupland KB (2013) Defining the epidemiology of bloodstream infections: The 'gold standard' of population-based assessment. Epidemiol Infect 141: 2149-2157.
2. Al-Hasan MN, Eckel-Passow JE, Baddour LM (2012) Impact of healthcare-associated acquisition on community-onset gram-negative bloodstream infection: A population-based study: Healthcare-associated gram-negative BSI. Eur J Clin Microbiol Infect Dis 31: 1163-1171.
3. Goto M, Al-Hasan MN (2013) Overall burden of bloodstream infection and nosocomial bloodstream infection in north america and europe. Clin Microbiol Infect.
4. Presterl E, Daxbock F, Graninger W, Willinger B (2007) Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the university hospital of vienna, austria. Clin Microbiol Infect 13: 1072-1076. (Pubitemid 47543107)
5. Arendrup MC, Cuenca-Estrella M, Donnelly JP, Lass-Florl C, Rodriguez-Tudela JL (2009) Association of fluconazole pharmacodynamics with mortality in patients with candidemia. Antimicrob Agents Chemother 53: 2704-5; author reply 2705-6.
6. Hoenigl M, Zollner-Schwetz I, Sill H, Linkesch W, Lass-Florl C, et al (2011) Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies. Mycoses 54: 454-459.
7. Zirkel J, Klinker H, Kuhn A, Abele-Horn M, Tappe D, et al (2012) Epidemiology of candida blood stream infections in patients with hematological malignancies or solid tumors. Med Mycol 50: 50-55.
8. Frederiksen MS, Espersen F, Frimodt-Moller N, Jensen AG, Larsen AR, et al (2007) Changing epidemiology of pediatric staphylococcus aureus bacteremia in denmark from 1971 through 2000. Pediatr Infect Dis J 26: 398-405. (Pubitemid 46789320)
9. Safdar A, Rodriguez GH, Balakrishnan M, Tarrand JJ, Rolston KV (2006) Changing trends in etiology of bacteremia in patients with cancer. Eur J Clin Microbiol Infect Dis 25: 522-526.
10. Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, et al (2004) Severe bloodstream infections: A population-based assessment. Crit Care Med 32: 992-997. (Pubitemid 38471521)
11. de Kraker ME, Davey PG, Grundmann H, BURDEN study group (2011) Mortality and hospital stay associated with resistant staphylococcus aureus and escherichia coli bacteremia: Estimating the burden of antibiotic resistance in europe. PLoS Med 8: e1001104.
12. de Kraker ME, Jarlier V, Monen JC, Heuer OE, van de Sande N, et al (2012) The changing epidemiology of bacteraemias in europe: Trends from the european antimicrobial resistance surveillance system. Clin Microbiol Infect.
13. Goncalves-Pereira J, Povoa PR, Lobo C, Carneiro AH (2013) Bloodstream infections as a marker of community-acquired sepsis severity. results from the portuguese community-acquired sepsis study (SACiUCI study). Clin Microbiol Infect 19: 242-248.
14. Hoenigl M, Raggam RB, Wagner J, Valentin T, Leitner E, et al (2013) Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome. Clin Biochem 46: 225-229.
15. Raggam RB, Wagner J, Pruller F, Grisold A, Leitner E, et al (2014) Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome. J Intern Med.
16. Rowther FB, Rodrigues CS, Deshmukh MS, Kapadia FN, Hegde A, et al (2009) Prospective comparison of eubacterial PCR and measurement of procalcitonin levels with blood culture for diagnosing septicemia in intensive care unit patients. J Clin Microbiol 47: 2964-2969.
17. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16: 128-140.
18. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al (2009) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. the ACCP/SCCM consensus conference committee. american college of chest Physicians/Society of critical care medicine. 1992. Chest 136: e28.
19. Rahkonen M, Luttinen S, Koskela M, Hautala T (2012) True bacteremias caused by coagulase negative staphylococcus are difficult to distinguish from blood culture contaminants. Eur J Clin Microbiol Infect Dis 31: 2639-2644.
20. Leal J, Gregson DB, Ross T, Flemons WW, Church DL, et al (2010) Development of a novel electronic surveillance system for monitoring of bloodstream infections. Infect Control Hosp Epidemiol 31: 740-747.
21. Anderson DJ, Moehring RW, Sloane R, Schmader KE, Weber DJ, et al (2014) Bloodstream infections in community hospitals in the 21st century: A multicenter cohort study. PLoS One 9: e91713.
22. Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, et al (2003) Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 41: 3655-3660. (Pubitemid 36994698)
23. Rodriguez-Bano J, Lopez-Prieto MD, Portillo MM, Retamar P, Natera C, et al (2010) Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clin Microbiol Infect 16: 1408-1413.
24. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, et al (1997) The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24: 584-602. (Pubitemid 27143552)
25. Kollef MH, Zilberberg MD, Shorr AF, Vo L, Schein J, et al (2011) Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: A multicenter cohort study. J Infect 62: 130-135.
26. Rodriguez-Bano J, Picon E, Gijon P, Hernandez JR, Cisneros JM, et al (2010) Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing escherichia coli. J Clin Microbiol 48: 1726-1731.
27. Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM (2012) Predictive scoring model of mortality in gram-negative bloodstream infection. Clin Microbiol Infect.
28. de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, et al (2010) Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care 14: R192.
29. de Jager CP, Wever PC, Gemen EF, Kusters R, van Gageldonk-Lafeber AB, et al (2012) The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS One 7: e46561.
30. Laupland KB, Kibsey PC, Galbraith JC (2012) Community-onset bloodstream infection during the 'after hours' is not associated with an increased risk for death. Can J Infect Dis Med Microbiol 23: 170-172.
31. Ho KM, Lipman J (2009) An update on C-reactive protein for intensivists. Anaesth Intensive Care 37: 234-241.
32. Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM (2011) Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol 135: 182-189.
33. Ratzinger F, Schuardt M, Eichbichler K, Tsirkinidou I, Bauer M, et al (2013) Utility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patients. PLoS One 8: e82946.